Lance A Berry
CIK 1478716 · EVP, COO, CFO & Treasurer · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.49M
Companies
6
Total Filings
72
Lifetime Open-Market Net
-$13.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TMCI | Director | 74,593 | $4.77 | $355.8K | $0 | 5 | 2026-05-19 |
| AORT | EVP, COO, CFO & Treasurer | 217,143 | $28.25 | $6.14M | -$993.5K | 8 | 2026-03-04 |
| VAPOTHERM INC (VAPO) Delisted | Director | 19,486 | $2.17 | $42.3K | $149.8K | 8 | 2023-07-28 |
| Wright Medical Group N.V. (WMGI) Delisted | EVP, Chief Finan./Op. Officer | 187,053 | — | — | -$8.75M | 8 | 2020-08-19 |
| Wright Medical Group N.V. (WMGIZ) Delisted | EVP, CFO & Operations Officer | 125,209 | — | — | -$584.7K | 6 | 2019-03-05 |
| Wright Medical Group N.V. (WMGI.Z) Delisted | Sr. VP and CFO | 115,280 | — | — | -$3.13M | 17 | 2016-07-21 |
Recent Filings · Page 2 of 8
72 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-04 | AORT | Grant (A) | +34,435 | $0 | EDGAR |
| 2025-02-26 | AORT | Sell (S) | −3,259 | -$89.0K | EDGAR |
| 2024-09-24 | — | Disp (D) | −25,485 | -$55.6K | |
| 2024-05-22 | TMCI | Grant (A) | +15,091 | $0 | EDGAR |
| 2024-02-26 | AORT | Grant (A) | +37,000 | $0 | EDGAR |
| 2024-01-03 | — | Grant (A) | +6,000 | $60.0K | |
| 2023-12-08 | AORT | Grant (A) | +42,064 | $750.0K | EDGAR |
| 2023-07-28 | VAPOTHERM INC (VAPO) Delisted | Grant (A) | +21,000 | $0 | EDGAR |
| 2023-05-25 | TMCI | Grant (A) | +2,753 | $0 | EDGAR |
| 2023-02-14 | VAPOTHERM INC (VAPO) Delisted | Buy (P) | +95,238 | $100.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.